Dietary exposure to 2-aminoanthracene induces morphological and immunocytochemical changes in pancreatic tissues of fisher-344 rats

Toxicological Sciences

Volumn 93, Issue 1, 2006, Pages 50-61

  Boudreau, M D ^a   Taylor, H W ^a   Baker, D G ^a   Means, Jay C ^a,b  

^a LOUISIANA STATE UNIVERSITY   (United States)

^b WESTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

2 aminoanthracene; Blood glucose; Immunoenzyme; Insulin; Islets of Langerhans; Rats

Indexed keywords

2 AMINOANTHRACENE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL DEATH; CELL STRUCTURE; CONTROLLED STUDY; CYTOLOGY; CYTOPLASM VESICLE; DIABETES MELLITUS; DIABETOGENESIS; FOOD CONTAMINATION; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; INSULIN DEFICIENCY; MALE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TUMOR; PROTEIN DETERMINATION; RAT; RAT STRAIN; SYMPTOM; TOXIN ANALYSIS; TUMOR GROWTH;

ANIMALS; ANTHRACENES; DIET; GENES, MYC; GENES, RAS; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; PANCREAS; RATS; RATS, INBRED F344; WEIGHT GAIN;

EID: 33747882461     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfl033     Document Type: Article

References (60)

1. Alder, V. A., Yu, D. Y., Su, E. N., and Cringle, S. J. (1992). Comparison of hematologic parameters in normal and streptozotocin-induced rats. Lab Anim. Sci. 42, 170-173.
2. American Institute of Nutrition (1993). AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J. Nutr. 123, 1939-1951.
3. Arcos, J. C., and Argus, M. F. (1974). Chemical Induction of Cancer, Structural Basis and Biological Mechanisms, Vol. IIB, pp. 13-17. Academic Press, New York.
4. Boudreau, M. D., Baker, D. G., Taylor, H. W., Barker, S. A., and Means, J. C. (2001). Suppression of arylamine toxicity in the fisher 344 rat following ingestion of a complex mixture. Toxicol. Pathol. 29, 333-343.
5. Brodrick, T. L., Kopp, S. J., Daar, J. T., Romano, F. D., and Paulson, D. J. (1993). Relation of glycosylated hemoglobin to in vivo cardiac function in response to dobutamine in spontaneously diabetic BB Wor rats. Can. J. Physiol. Pharmacol. 72, 722-727.
6. Bunn, H. F. (1981). Non-enzymatic glycosylation of protein: Relevance to diabetes. Am. J. Med. 70, 325-330.
7. Burrows, A. W., Hockaday, T. D. R., Mann, J. I., and Taylor, J. G. (1978). Diabetic dimorphism according to acetylator status. Br. Med. J. 1, 208-210.
8. PA (P-4501A2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl. Acad. Sci. U.S.A. 86, 7696-7700.
9. Carriere, V., deWaziers, I., Courtois, Y. A., Leroux, J. P., and Beaune, P. H. (1992). Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2-AA) in rat liver and gut. Mutat. Res. 268, 11-20.
10. Cartwright, R. A. (1983). Historical and modern epidemiological studies on populations exposed to N-substituted aryl compounds. Environ. Health Perspect. 49, 13-19.
11. Cooperstein, S. J., and Watkins, D. (1981). Action of toxic drugs on islet cells. In The islets of Langerhans, Biochemistry, Physiology, and Pathology (S. J. Cooperstein and D. Watkins, Eds.), pp. 387-394. Academic Press, New York.
12. DeTata, V., Novelli, M., Bombara, M., Masiello, P., Cappuccio, A., Innocenti, B., and Bergamini, E. (1996). Determination of glycated hemoglobins in the rat: Comparison between two different chromatographic methods and application in experimental diabetology. Res. Exp. Med. 196, 9-16.
13. Elayat, A. A., El-Naggar, M. M., and Tahir, M. (1995). An immunocytochemical and morphometric study of the rat pancreatic islets. J. Anat. 186, 629-637.
14. Farber, O. K., Christensen, H., Kehlet, S., Madsbad, S., and Binder, C. (1981). Decreased insulin removal contributes to hyperinsulinemia in obesity. J. Clin. Endocrinol. Metab. 53, 618-621.
15. Farquharson, C., Hesketh, J. E., and Loveridge, N. (1992). The proto-oncogene C-myc is involved in cell differentiation as well as cell proliferation: Studies on growth plate chondrocytes in situ. J. Cell. Physiol. 152, 135-144.
16. Fu, P. P., Heflich, R. H., Von Tungeln, L. S., Yang, D. T. C., Fifer, E. K., and Beland, F. A. (1986). Effect of the nitro group conformation on the rat liver microsomal metabolism and bacterial mutagenicity of 2- and 9-nitro-anthracene. Carcinogenesis 7, 1819-1827.
17. Garner, R. C., Martin, C. N., and Clayson, D. B. (1984). Carcinogenic aromatic amines and related compounds. In Chemical Carcinogens (C. E. Searle, Ed.), 2nd ed., Vol. 1, pp. 175-263. Washington, DC, American Chemical Society, ACS monograph 182.
18. Gorrod, J. W., and Manson, D. (1986). The metabolism of aromatic amines. Xenobiotica 16, 933-955.
19. Hallstrom, I., Sundvall, A., Rannug, U., Grafstrom, R., and Ramel, C. (1981). The metabolism of drugs and carcinogens in isolated sub-cellular fractions of Drosophila melanogaster. I. Activation of vinyl chloride, 2-aminoanthracene and benzo[a]pyrene as measured by mutagenic effects in Salmonella typhimurium. Chem. Biol. Interact. 34, 129-143.
20. Hanai, N. (1984). Morphological and immunocytochemical study of rat pancreatic beta cell changes induced by cyclizine. J. Appl. Toxicol. 4, 308-314.
21. Hasmall, S. C., Pyrah, I. T. G., Soames, A. R., and Roberts, R. A. (1997). Expression of the immediate-early genes, c-fos,c-jun, and c-myc:A comparison in rats of nongenotoxic hepatocarcinogens with noncarcinogenic liver mitogens. Fundam. Appl. Toxicol. 40, 129-137.
22. Heaton, D. A., Millward, B. A., Gray, I. P., Tun, Y., Hales, C. N., Pyke, D. A., and Leslie, R. D. G. (1988). Increased proinsulin levels as an early indicator of b-cell dysfunction in non-diabetic twins of type I (insulin dependent) diabetic parents. Diabetologia 31, 182-184.
23. Hosgood, G. (1996). Ranges of glucose and glycated hemoglobin levels in Sprague-Dawley rats (unpublished data).
24. Hsu, S., Raine, L., and Fanger, H. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
25. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Samashia, M., Hase, A., Seto, Y., and Nagata, S. (1991). The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
26. Jaspan, J., and Polonsky, K. S. (1982). Glucose ingestion in dogs alters the hepatic extraction of insulin: In vivo evidence for a relationship between biologic action and extraction of insulin. J. Clin. Invest. 69, 516-525.
27. Kadish, A., Little, R., and Sternberg, J. (1968). A new and rapid method for the determination of glucose by measurement of rate of oxygen consumption. Clin. Chem. 14, 116-121.
28. Kriek, E. (1979). Aromatic amines and related compounds as carcinogenic hazards to man. In Environmental Carcinogenesis, Occurrence, Risk Evaluation and Mechanisms (P. Emmelot and E. Kriek, Eds.), pp. 143-164. Elsevier/North-Holland Biomedical Press, New York.
29. Lentz, S., Eversole, R., Law, J. M., and Means, J. C. (2006). Cellular proliferation, cell death and histology of G. affinis livers after exposure to benzidine and 2-aminofluorene. Toxicol. Pathol. (in press).
30. Lentz, S., Eversole, R., and Means J. C. (2003). Screening of biomarkers for histological examination of cellular proliferation and death in the livers of the western mosquitofish, Gambusia affinis. J. Histotechnol. 26, 157-166.
31. Longnecker, D. S., Wold, J. S., and Fischer, L. J. (1972). Ultrastructural study of alterations in beta cells of pancreatic islets from cyproheptadine-treated rats. Diabetes 21, 71-79.
32. Lu, L., and Logsdon, C. D. (1992). CCK, bombesin, and carbachol stimulate c-fos, and c-myc oncogene expression in rat pancreatic acini. Am. J. Physiol. 263(Pt 1), G327-G332.
33. Malaisse, W. J. (1986). The endocrine pancreas as a target organ for toxicity. In Target Organ Toxicity (G. M. Cohen, Ed.), Vol. 2, pp. 144-157. CRC Press, Inc, Boca Raton, FL.
34. Martell, K. J., and Weber, W. W. (1993). N-acetylation polymorphism in liver and pancreas of inbred rats. Drug Metab. Dispos. 21, 965-966.
35. Mathias, D., Vence, L., and Benoist, C. (2001). B-cell death during progression to diabetes. Nature 414, 792-798.
36. McEvoy, R. C., and Hegre, O. D. (1977). Morphometric quantitation of the pancreatic insulin-, glucagon-, and somatostatin-positive cell populations in normal and alloxan-diabetic rats. Diabetes 26, 1140-1146.
37. Means, J. C., Olsen, P. D., and Schoffers, E. (2003). Development of an isotope dilution liquid chromatography/tandem mass spectrometry detection method for DNA adducts of selected aromatic amines. J. Am. Soc. Mass Spectrom. 14, 1057-1066.
38. Morgan, C. R., and Lazarow, A. (1963). Immunoassay of insulin: Two antibody system. Plasma insulin levels of normal, subdiabetic and diabetic rats. Diabetes 12, 115-126.
39. Orci, L. (1982). Macro- and micro-domains in the endocrine pancreas. Diabetes 31, 538-565.
40. Orci, L., and Unger, R. H. (1976). Functional subdivision of the islets of Langerhans and possible role of D cell. Life Sci. 19, 1811-1816.
41. Pieper, G. M., Siebeneich, W., Roza, A. M., Jordan, M., and Admas, M. B. (1996). Chronic treatment in vivo with dimethylthiourea, a hydroxyl radical scavenger, prevents diabetes-induced endothelial dysfunction. J. Cardiovasc. Pharmacol. 28, 741-745.
42. Polonsky, K. S. (1995). The b-cell in diabetes: From molecular genetics to clinical research. Diabetes 44, 705-717.
43. Porte D., Jr, and Schwartz, M. W. (1996). Diabetes complications: Why is glucose potentially toxic? Science 272, 699-700.
44. Rabinovitch, A., Suarez-Pinzon, W. L., Sorensen, O., and Bleackley, R. C. (1996a). Inducible nitric oxide synthase (iNOS) in pancreatic islets of non-obese diabetic mice: Identification of iNOS expressing cells and relationships to cytokines expressed in the islets. Endocrinology 137, 2093-2099.
45. Rabinovitch, A., Suarez-Pinzon, W. L., Strynadka, K., Lakey, J. R. T., and Rajotte, R. V. (1996b). Human pancreatic islet b-cell destruction by cytokines involves oxygen free radicals and aldehyde production. J. Clin. Endocrinol. Metab. 81, 3197-3202.
46. Rerup, C. C. (1970). Drugs producing diabetes through damage of the insulin secreting cells. Pharmacol. Rev. 22, 485-513.
47. Richmond, R. E., Periera, M. A., Carter, J. H., Carter, H. W., and Long, R. E. (1988). Quantitative and qualitative immunohistochemical detection of myc and src oncogene proteins in normal, nodule, and neoplastic rat liver. J. Histochem. Cytochem. 36, 179-184.
48. Roberts, R. A., Hebert, D. W., Hickman, J. A., Richburg, J. H., and Goldsworthy, T. L. (1997). Perturbation of the mitosis/apoptosis balance: A fundamental mechanism in toxicology. Fundam. Appl. Toxicol. 38, 107-115.
49. Rodrigues, A. S., Silva, I. D., Caria, M. H., Laires, A., Chaveca, T., Glatt, H. R., and Rueff, J. (1993). Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells. Mutat. Res. 341, 93-100.
50. Scaglia, L., Cahill, C. J., Finegood, D. T., and Bonner-Weir, S. (1997). Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology 138, 1736-1741.
51. Shear, M. J. (1983). Carcinogenic activity of some anthracene derivatives. J. Biol. Chem. 123, 108-110.
52. Shubik, P., Pietra, G., and Porta, G. D. (1960). Studies of skin carcinogenesis in the Syrian golden hamster. Cancer Res. 20, 100-105.
53. Snyderwine, E. G., Schut, H. A. J., Adamson, R. H., and Thorgeirsson, U. O. (1992). Metabolic activation and genotoxicity of heterocyclic arylamines. Cancer Res. 52(Suppl.), 2099s-2102s.
54. Sprankle, C. S., Larson, J. L., Goldsworthy, S. M., and Butterworth, B. E. (1996). Levels of myc, fos, Ha-ras, met and hepatocyte growth factor mRNA during regenerative cell proliferation in female mouse liver and male rat kidney after a cytotoxic dose of chloroform. Cancer Lett. 101, 97-106.
55. Stefan, Y., Orci, L., Malaisse-Lagae, F., Perrelet, A., Patel, Y., and Unger, R. H. (1982). Quantitation of endocrine cell content in the pancreas of non-diabetic and diabetic humans. Diabetes 31, 694-700.
56. Suda, T., Takahashi, T., Golstein, P., and Nagata, S. (1993). Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
57. Vineis, P. (1992). The use of biomarkers in epidemiology: The example of bladder cancer. Toxicol. Lett. 64/65, 463-467.
58. Vineis, P. (1994). Epidemiology of cancer from exposure to arylamines. Environ. Health Perspect. 102(Suppl. 6), 7-10.
59. Westphal, S., and Kalthoff, H. (2003). Apoptosis: Targets in pancreatic cancer. Mol. Cancer 2, 6-20.
60. Zhu, Y., Bye, S., Stambrook, P. J., and Tischfield, J. A. (1995). Aflatoxin B1, 2-aminoanthracene, and 7,12-dimethylbenz[a]anthracene-induced frameshift mutations in human APRT. Environ. Mol. Mutagen. 26, 234-239.